Human CXCL12/SDF-1 beta Antibody

Catalog # Availability Size / Price Qty
Chemotaxis Induced by CXCL12/SDF‑1 beta  and Neutral-ization by Human CXCL12/ SDF‑1 beta  Antibody.
1 Image
Product Details
Citations (1)
Supplemental Products

Human CXCL12/SDF-1 beta Antibody Summary

Species Reactivity
Detects human CXCL12/SDF‑1 beta in direct ELISAs and Western blots. Neutralizes 60‑80% of the biological activity of CXCL12/SDF-1 beta and does not neutralize the biological activity of SDF‑1 alpha. In Western blots, less than 5% cross-reactivity with recombinant human SDF-1 alpha is observed.
Polyclonal Goat IgG
Antigen Affinity-purified
E. coli-derived recombinant human CXCL12/SDF‑1 beta
Accession # P48061
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.


Recommended Concentration
Western Blot
0.1 µg/mL
Recombinant Human/Feline CXCL12/SDF‑1 beta aa 19-93 (Catalog # 2716-SD)
Measured by its ability to neutralize CXCL12/SDF‑1 beta -induced chemotaxis in the BaF3 mouse pro‑B cell line transfected with human CXCR4. The Neutralization Dose (ND50) is typically 10-30 µg/mL in the presence of 10 ng/mL Recombinant Human/Feline CXCL12/SDF‑1 beta.

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Neutralization Chemotaxis Induced by CXCL12/SDF‑1 beta  and Neutral-ization by Human CXCL12/ SDF‑1 beta  Antibody. View Larger

Chemotaxis Induced by CXCL12/SDF‑1 beta and Neutral-ization by Human CXCL12/ SDF‑1 beta Antibody. Recombinant Human/Feline CXCL12/SDF-1 beta chemo-attracts the BaF3 mouse pro-B cell line transfected with human CXCR4 in a dose-dependent manner (orange line). The amount of cells that migrated through to the lower chemotaxis chamber was measured by Resazurin (Catalog # AR002). Chemotaxis elicited by Recombinant Human/Feline CXCL12/ SDF-1 beta (10 ng/mL) is neutral-ized (green line) by increasing concentrations of Goat Anti-Human CXCL12/SDF-1 beta Anti-gen Affinity-purified Poly-clonal Antibody (Catalog # AF-351-NA). The ND50 is typically 10-30 µg/mL.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Preparation and Storage

Reconstitute at 0.2 mg/mL in sterile PBS.
Reconstitution Buffer Available
Reconstitution Buffer 1 (PBS)
Catalog #
Size / Price
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: CXCL12/SDF-1 beta

CXCL12, also known as SCYB12, PBSF and SDF-1 beta, is an 8.3 kDa, heparin-binding member of the CXC (or alpha-) family of chemokines (1, 2). Feline CXCL12( beta ) is synthesized as a 93 amino acid (aa) precursor that contains a 21 aa signal sequence and a 72 aa mature region (3). The mature molecule exhibits a typical three antiparallel beta -strand chemokine-like fold. There are no potential N-linked glycosylation sites. N-terminal aa’s 1 - 8 form a receptor binding site, while aa’s 1 and 2 (Lys-Pro) are involved in receptor activation (4). The C-terminus is likely associated with heparin binding (5). SDF-1 beta circulates and undergoes proteolytic processing. CD26 will remove the first two N-terminal amino acids, possibly creating a reduced-activity chemokine (5, 6). In addition to the beta -isoform, alternate splicing of the feline SDF-1 gene generates an alpha -isoform. The alpha isoform is identical to SDF-1 beta, but shorter by four aa’s at the C-terminus (3). Although alpha - and beta -isoforms show similar activity, SDF-1 alpha is differentially processed, and different cells secrete the two isoforms (5, 7). Mature feline SDF-1 beta is 96%, 97% and 100% aa identical to rat, mouse and human SDF-1 beta, respectively. Human (and by inference, feline) SDF-1 is active on mouse cells. SDF-1 alpha and beta are reported to be monomers at neutral pH and physiologic ionic strength (4). SDF-1 alpha is also reported to form dimers in the presence of heparansulfate (8). On the cell surface, this may well facilitate SDF-1 interaction with its two receptors, CXCR4 and syndecan-4 (9). Heparin sulfate is known to protect SDF-1 from proteolysis, and CXCR4 exists constitutively as a dimer (9 - 11). Among its many functions, CXCL12 is known to influence lymphopoiesis, regulate patterning and cell number of neural progenitors, and promote angiogenesis (12, 13). It also enhances the survival of myeloid progenitor cells.

  1. Zlotnik, A. and O. Yoshie (2000) Immunity 12:121.
  2. Rollins, B.J. (1997) Blood 90:909.
  3. Nishimura, Y. et al. (1998) Eur. J. Immunogenet. 25:303.
  4. Crump, M.P. et al. (1997) EMBO J. 16:6996.
  5. Sierra, M.D. L. et al. (2004) Blood 103:2452.
  6. Davis, D.A. et al. (2005) Blood 105:4561.
  7. Stumm, R.K. et al. (2002) J. Neurosci. 22:5865.
  8. Veldkamp, C.T. et al. (2005) Protein Sci. 14:1071.
  9. Charnaux, N. et al. (2005) FEBS J. 272:1937.
  10. Percherancier, Y. et al. (2005) J. Biol. Chem. 280:9895.
  11. Babcock, G.J. et al. (2003) J. Biol. Chem. 278:3378.
  12. Klein, R.S. et al. (2004) Trends Immunol. 25:306.
  13. Salcedo, R. and J.J. Oppenheim (2003) Microcirculation 10:359.
  14. Broxmeyer, H.E. et al. (2003) J. Leukoc. Biol. 73:630.
Entrez Gene IDs
6387 (Human); 20315 (Mouse); 493806 (Feline)
Alternate Names
CXCL12/SDF-1 beta; hSDF-1beta; SDF 1beta; SDF1 beta; SDF1b

Product Datasheets

You must select a language.


Citation for Human CXCL12/SDF-1 beta Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

1 Citation: Showing 1 - 1

  1. Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9.
    Authors: Kenig S, Alonso MB, Mueller MM, Lah TT
    Cancer Lett., 2010;289(1):53-61.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization


No product specific FAQs exist for this product, however you may

View all Antibody FAQs

Isotype Controls

Reconstitution Buffers

Secondary Antibodies

Goat IgG (H+L) Antibody


Reviews for Human CXCL12/SDF-1 beta Antibody

There are currently no reviews for this product. Be the first to review Human CXCL12/SDF-1 beta Antibody and earn rewards!

Have you used Human CXCL12/SDF-1 beta Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review